| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Robotic Surgical Procedures | 50 | 2022 | 227 | 24.040 |
Why?
|
| Coronary Artery Disease | 24 | 2022 | 332 | 11.650 |
Why?
|
| Endoscopy | 32 | 2022 | 315 | 11.390 |
Why?
|
| Coronary Artery Bypass | 33 | 2023 | 207 | 11.160 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 14 | 2022 | 35 | 8.570 |
Why?
|
| Cardiac Surgical Procedures | 15 | 2022 | 448 | 5.920 |
Why?
|
| Robotics | 14 | 2022 | 255 | 5.910 |
Why?
|
| Percutaneous Coronary Intervention | 6 | 2022 | 53 | 4.490 |
Why?
|
| Coronary Vessels | 7 | 2020 | 182 | 3.940 |
Why?
|
| Mammary Arteries | 9 | 2022 | 26 | 3.470 |
Why?
|
| Minimally Invasive Surgical Procedures | 16 | 2023 | 213 | 3.380 |
Why?
|
| Heart Valve Prosthesis Implantation | 6 | 2021 | 149 | 3.230 |
Why?
|
| Mitral Valve Insufficiency | 7 | 2022 | 181 | 2.940 |
Why?
|
| Aortic Valve | 7 | 2022 | 197 | 2.360 |
Why?
|
| Treatment Outcome | 31 | 2023 | 7589 | 2.170 |
Why?
|
| Anastomosis, Surgical | 7 | 2021 | 287 | 1.860 |
Why?
|
| Retrospective Studies | 26 | 2022 | 7600 | 1.760 |
Why?
|
| Vascular Patency | 8 | 2020 | 119 | 1.760 |
Why?
|
| Pericardiectomy | 4 | 2020 | 9 | 1.750 |
Why?
|
| Heart Neoplasms | 3 | 2019 | 57 | 1.600 |
Why?
|
| Humans | 83 | 2023 | 81308 | 1.590 |
Why?
|
| Aged | 35 | 2022 | 17570 | 1.470 |
Why?
|
| Coronary Angiography | 7 | 2020 | 205 | 1.290 |
Why?
|
| Middle Aged | 37 | 2021 | 24127 | 1.270 |
Why?
|
| Myocardial Revascularization | 3 | 2021 | 31 | 1.240 |
Why?
|
| Male | 46 | 2021 | 39770 | 1.230 |
Why?
|
| Length of Stay | 10 | 2020 | 658 | 1.180 |
Why?
|
| Obesity, Morbid | 2 | 2018 | 206 | 1.130 |
Why?
|
| Carbapenems | 2 | 2016 | 9 | 1.080 |
Why?
|
| Acinetobacter Infections | 2 | 2016 | 14 | 1.080 |
Why?
|
| beta-Lactam Resistance | 2 | 2016 | 13 | 1.070 |
Why?
|
| Thoracic Surgery | 2 | 2021 | 39 | 1.040 |
Why?
|
| Mitral Valve | 7 | 2022 | 237 | 1.030 |
Why?
|
| Aortic Valve Stenosis | 3 | 2021 | 116 | 1.010 |
Why?
|
| Female | 37 | 2021 | 42685 | 0.960 |
Why?
|
| Atrial Fibrillation | 4 | 2020 | 248 | 0.940 |
Why?
|
| Fibroma | 2 | 2019 | 30 | 0.920 |
Why?
|
| Pulmonary Veins | 2 | 2020 | 64 | 0.920 |
Why?
|
| Reoperation | 3 | 2019 | 573 | 0.900 |
Why?
|
| Heart Valve Diseases | 2 | 2019 | 98 | 0.890 |
Why?
|
| One-Lung Ventilation | 2 | 2020 | 4 | 0.880 |
Why?
|
| Aged, 80 and over | 16 | 2019 | 6244 | 0.850 |
Why?
|
| Scimitar Syndrome | 1 | 2020 | 3 | 0.820 |
Why?
|
| Cross Infection | 2 | 2012 | 131 | 0.820 |
Why?
|
| Anti-Bacterial Agents | 3 | 2016 | 714 | 0.810 |
Why?
|
| Vena Cava, Superior | 1 | 2020 | 58 | 0.790 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2020 | 66 | 0.780 |
Why?
|
| Mortality | 2 | 2018 | 148 | 0.770 |
Why?
|
| Pericarditis | 1 | 2019 | 13 | 0.770 |
Why?
|
| Analgesia | 2 | 2021 | 57 | 0.770 |
Why?
|
| Sutureless Surgical Procedures | 1 | 2019 | 6 | 0.750 |
Why?
|
| Physician Assistants | 1 | 2019 | 17 | 0.750 |
Why?
|
| Mitral Valve Stenosis | 1 | 2019 | 37 | 0.740 |
Why?
|
| Angioplasty, Balloon | 1 | 2019 | 96 | 0.730 |
Why?
|
| Follow-Up Studies | 7 | 2022 | 3586 | 0.730 |
Why?
|
| Aorta | 2 | 2019 | 297 | 0.720 |
Why?
|
| Blood Loss, Surgical | 1 | 2019 | 108 | 0.720 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 98 | 0.720 |
Why?
|
| Operative Time | 4 | 2019 | 111 | 0.720 |
Why?
|
| Tertiary Care Centers | 3 | 2016 | 85 | 0.700 |
Why?
|
| Blood Transfusion | 1 | 2019 | 150 | 0.700 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2019 | 120 | 0.690 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2018 | 99 | 0.690 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 172 | 0.680 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2017 | 9 | 0.640 |
Why?
|
| Suture Techniques | 1 | 2018 | 130 | 0.640 |
Why?
|
| Cardiopulmonary Bypass | 4 | 2020 | 143 | 0.630 |
Why?
|
| Acinetobacter baumannii | 1 | 2016 | 21 | 0.620 |
Why?
|
| Pericarditis, Constrictive | 1 | 2016 | 5 | 0.610 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2018 | 218 | 0.610 |
Why?
|
| Postoperative Complications | 5 | 2018 | 2101 | 0.600 |
Why?
|
| Equipment Design | 5 | 2018 | 400 | 0.600 |
Why?
|
| Hemorrhage | 1 | 2018 | 237 | 0.600 |
Why?
|
| Heart Ventricles | 2 | 2019 | 724 | 0.600 |
Why?
|
| beta-Lactamases | 1 | 2016 | 58 | 0.590 |
Why?
|
| Catheter Ablation | 2 | 2016 | 217 | 0.590 |
Why?
|
| Transcatheter Aortic Valve Replacement | 3 | 2022 | 42 | 0.590 |
Why?
|
| Bupivacaine | 1 | 2015 | 45 | 0.580 |
Why?
|
| Laparoscopy | 1 | 2022 | 684 | 0.570 |
Why?
|
| Anesthetics, Local | 1 | 2015 | 81 | 0.560 |
Why?
|
| Heart Diseases | 1 | 2017 | 289 | 0.550 |
Why?
|
| Pain Management | 1 | 2015 | 123 | 0.530 |
Why?
|
| Risk Factors | 8 | 2021 | 5177 | 0.490 |
Why?
|
| Coronary Stenosis | 1 | 2013 | 39 | 0.480 |
Why?
|
| Postoperative Period | 3 | 2019 | 296 | 0.480 |
Why?
|
| Acinetobacter | 1 | 2012 | 4 | 0.470 |
Why?
|
| Klebsiella Infections | 1 | 2012 | 23 | 0.450 |
Why?
|
| Klebsiella pneumoniae | 1 | 2012 | 33 | 0.440 |
Why?
|
| Disease Outbreaks | 1 | 2012 | 161 | 0.420 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2020 | 337 | 0.410 |
Why?
|
| Adult | 12 | 2021 | 24771 | 0.410 |
Why?
|
| Heart Valve Prosthesis | 2 | 2022 | 88 | 0.400 |
Why?
|
| Coronary Disease | 1 | 2011 | 271 | 0.390 |
Why?
|
| Saudi Arabia | 3 | 2016 | 16 | 0.390 |
Why?
|
| Tricuspid Valve | 2 | 2020 | 88 | 0.380 |
Why?
|
| Cardiac Resynchronization Therapy | 2 | 2020 | 63 | 0.370 |
Why?
|
| Perioperative Period | 2 | 2019 | 27 | 0.370 |
Why?
|
| Heart Failure | 1 | 2018 | 1099 | 0.360 |
Why?
|
| Heart Atria | 2 | 2016 | 236 | 0.360 |
Why?
|
| Computed Tomography Angiography | 2 | 2020 | 107 | 0.360 |
Why?
|
| Heart | 2 | 2023 | 502 | 0.350 |
Why?
|
| Combined Modality Therapy | 3 | 2018 | 1626 | 0.340 |
Why?
|
| Pericardium | 2 | 2019 | 68 | 0.330 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2018 | 59 | 0.330 |
Why?
|
| Prosthesis Design | 2 | 2019 | 269 | 0.330 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2020 | 181 | 0.330 |
Why?
|
| Stroke Volume | 2 | 2022 | 413 | 0.330 |
Why?
|
| Surgeons | 2 | 2021 | 192 | 0.320 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2017 | 641 | 0.310 |
Why?
|
| Feasibility Studies | 2 | 2019 | 724 | 0.310 |
Why?
|
| Echocardiography, Three-Dimensional | 3 | 2017 | 497 | 0.300 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 562 | 0.300 |
Why?
|
| Hemodynamics | 2 | 2020 | 687 | 0.300 |
Why?
|
| Myocardial Infarction | 2 | 2019 | 347 | 0.290 |
Why?
|
| Chordae Tendineae | 2 | 2015 | 23 | 0.280 |
Why?
|
| Analgesics, Opioid | 2 | 2021 | 376 | 0.270 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2019 | 98 | 0.270 |
Why?
|
| Endoscopes | 1 | 2004 | 9 | 0.260 |
Why?
|
| Surgical Stapling | 1 | 2004 | 17 | 0.260 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2016 | 150 | 0.260 |
Why?
|
| Microwaves | 1 | 2004 | 24 | 0.260 |
Why?
|
| Hospital Mortality | 2 | 2019 | 323 | 0.250 |
Why?
|
| Cluster Analysis | 2 | 2016 | 354 | 0.240 |
Why?
|
| Patient Positioning | 2 | 2020 | 57 | 0.240 |
Why?
|
| Sternum | 1 | 2022 | 25 | 0.240 |
Why?
|
| Heart Arrest, Induced | 1 | 2022 | 27 | 0.230 |
Why?
|
| Thoracotomy | 1 | 2022 | 56 | 0.230 |
Why?
|
| Cardiovascular Diseases | 1 | 2009 | 789 | 0.230 |
Why?
|
| Time Factors | 3 | 2019 | 5161 | 0.210 |
Why?
|
| Prognosis | 2 | 2019 | 3549 | 0.210 |
Why?
|
| Pulmonary Edema | 1 | 2021 | 51 | 0.210 |
Why?
|
| Morphine | 1 | 2021 | 129 | 0.210 |
Why?
|
| Myocardial Bridging | 1 | 2020 | 1 | 0.200 |
Why?
|
| Lead Poisoning | 1 | 2020 | 7 | 0.200 |
Why?
|
| Survival Analysis | 2 | 2017 | 1521 | 0.200 |
Why?
|
| Nobel Prize | 1 | 2020 | 10 | 0.200 |
Why?
|
| Mitral Valve Prolapse | 1 | 2020 | 22 | 0.200 |
Why?
|
| Simulation Training | 1 | 2021 | 84 | 0.200 |
Why?
|
| Congenital Abnormalities | 1 | 2020 | 60 | 0.200 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2020 | 36 | 0.200 |
Why?
|
| Epicardial Mapping | 1 | 2019 | 10 | 0.190 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2019 | 18 | 0.190 |
Why?
|
| Career Choice | 1 | 2021 | 137 | 0.190 |
Why?
|
| Multidetector Computed Tomography | 1 | 2020 | 51 | 0.190 |
Why?
|
| Pain | 1 | 2022 | 363 | 0.190 |
Why?
|
| Inservice Training | 1 | 2019 | 37 | 0.190 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 7 | 0.190 |
Why?
|
| History, 21st Century | 1 | 2020 | 169 | 0.190 |
Why?
|
| Young Adult | 3 | 2017 | 5754 | 0.180 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 133 | 0.180 |
Why?
|
| Bioprosthesis | 1 | 2019 | 36 | 0.180 |
Why?
|
| Genotype | 2 | 2016 | 1810 | 0.180 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2019 | 62 | 0.180 |
Why?
|
| Safety | 1 | 2019 | 157 | 0.180 |
Why?
|
| History, 20th Century | 1 | 2020 | 306 | 0.180 |
Why?
|
| Retreatment | 1 | 2018 | 106 | 0.180 |
Why?
|
| Vascular Calcification | 1 | 2019 | 38 | 0.180 |
Why?
|
| Interactive Ventilatory Support | 1 | 2018 | 5 | 0.180 |
Why?
|
| Surgical Staplers | 1 | 2018 | 10 | 0.170 |
Why?
|
| Recovery of Function | 1 | 2019 | 251 | 0.170 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2017 | 16 | 0.170 |
Why?
|
| Defibrillators, Implantable | 1 | 2019 | 129 | 0.170 |
Why?
|
| Radial Artery | 1 | 2017 | 25 | 0.170 |
Why?
|
| Gender Identity | 1 | 2018 | 42 | 0.170 |
Why?
|
| Saphenous Vein | 1 | 2017 | 59 | 0.170 |
Why?
|
| Morbidity | 1 | 2018 | 141 | 0.170 |
Why?
|
| Acute Disease | 1 | 2019 | 806 | 0.160 |
Why?
|
| Renal Insufficiency | 1 | 2018 | 105 | 0.160 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 219 | 0.160 |
Why?
|
| Child, Preschool | 2 | 2016 | 3569 | 0.160 |
Why?
|
| Echocardiography | 2 | 2019 | 866 | 0.160 |
Why?
|
| Prospective Studies | 2 | 2018 | 3955 | 0.160 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2017 | 76 | 0.160 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 1698 | 0.160 |
Why?
|
| Multilocus Sequence Typing | 1 | 2016 | 11 | 0.160 |
Why?
|
| Risk | 1 | 2018 | 673 | 0.160 |
Why?
|
| Atrial Septum | 1 | 2016 | 9 | 0.160 |
Why?
|
| Overweight | 1 | 2017 | 114 | 0.150 |
Why?
|
| Molecular Epidemiology | 1 | 2016 | 52 | 0.150 |
Why?
|
| Quality Improvement | 1 | 2020 | 369 | 0.150 |
Why?
|
| Coronary Sinus | 1 | 2016 | 6 | 0.150 |
Why?
|
| Recurrence | 1 | 2019 | 1116 | 0.150 |
Why?
|
| Prevalence | 2 | 2020 | 1190 | 0.150 |
Why?
|
| Ventricular Fibrillation | 1 | 2016 | 62 | 0.150 |
Why?
|
| Heart Conduction System | 1 | 2016 | 105 | 0.150 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2016 | 89 | 0.150 |
Why?
|
| Plasmids | 1 | 2016 | 282 | 0.150 |
Why?
|
| Liposomes | 1 | 2015 | 95 | 0.140 |
Why?
|
| Hypertonic Solutions | 1 | 1995 | 17 | 0.140 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 232 | 0.140 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 107 | 0.140 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 32 | 0.140 |
Why?
|
| Organ Preservation Solutions | 1 | 1995 | 27 | 0.140 |
Why?
|
| Pacemaker, Artificial | 1 | 2016 | 85 | 0.140 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2015 | 62 | 0.140 |
Why?
|
| Therapeutics | 1 | 2014 | 11 | 0.140 |
Why?
|
| Organ Preservation | 1 | 1995 | 73 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 2446 | 0.140 |
Why?
|
| Risk Assessment | 3 | 2021 | 2180 | 0.140 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 102 | 0.140 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 339 | 0.130 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 173 | 0.130 |
Why?
|
| Body Mass Index | 1 | 2018 | 745 | 0.130 |
Why?
|
| Device Removal | 1 | 2016 | 155 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 931 | 0.130 |
Why?
|
| Quality of Life | 1 | 2021 | 1401 | 0.130 |
Why?
|
| Comorbidity | 1 | 2017 | 924 | 0.130 |
Why?
|
| Pulmonary Artery | 1 | 1995 | 285 | 0.120 |
Why?
|
| Ischemia | 1 | 1995 | 244 | 0.120 |
Why?
|
| Child | 2 | 2016 | 6639 | 0.120 |
Why?
|
| Heart Arrest | 1 | 2016 | 253 | 0.120 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1747 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 832 | 0.120 |
Why?
|
| Heart Transplantation | 1 | 2018 | 656 | 0.120 |
Why?
|
| Software | 1 | 2017 | 638 | 0.120 |
Why?
|
| Internship and Residency | 1 | 2021 | 928 | 0.120 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2012 | 18 | 0.110 |
Why?
|
| Molecular Typing | 1 | 2012 | 15 | 0.110 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2012 | 43 | 0.110 |
Why?
|
| Wisconsin | 1 | 2011 | 38 | 0.110 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2012 | 91 | 0.110 |
Why?
|
| Heart-Assist Devices | 1 | 2019 | 702 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2012 | 2600 | 0.110 |
Why?
|
| Adolescent | 2 | 2016 | 8736 | 0.110 |
Why?
|
| Radiography | 1 | 2013 | 812 | 0.110 |
Why?
|
| Electrocardiography | 3 | 2019 | 468 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2013 | 388 | 0.100 |
Why?
|
| Obesity | 1 | 2017 | 927 | 0.100 |
Why?
|
| Infection Control | 1 | 2012 | 107 | 0.100 |
Why?
|
| Burns | 1 | 2012 | 113 | 0.100 |
Why?
|
| Hypertension | 1 | 2019 | 1207 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 2595 | 0.100 |
Why?
|
| Stroke | 1 | 2018 | 768 | 0.100 |
Why?
|
| Algorithms | 2 | 2017 | 1787 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2012 | 652 | 0.100 |
Why?
|
| Survival Rate | 2 | 2011 | 1820 | 0.100 |
Why?
|
| Lung | 1 | 1995 | 1104 | 0.090 |
Why?
|
| Angiography | 1 | 2009 | 201 | 0.090 |
Why?
|
| Intensive Care Units | 1 | 2012 | 347 | 0.090 |
Why?
|
| Myocardial Ischemia | 1 | 2009 | 153 | 0.090 |
Why?
|
| Image Enhancement | 3 | 2017 | 548 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 1947 | 0.080 |
Why?
|
| Hospitalization | 1 | 2012 | 770 | 0.080 |
Why?
|
| Infant | 1 | 2012 | 2965 | 0.070 |
Why?
|
| Clinical Competence | 2 | 2021 | 722 | 0.070 |
Why?
|
| Disease Progression | 1 | 2009 | 1436 | 0.070 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 92 | 0.060 |
Why?
|
| Injections, Spinal | 1 | 2021 | 43 | 0.060 |
Why?
|
| Decontamination | 1 | 2021 | 9 | 0.060 |
Why?
|
| Myocardial Contraction | 1 | 2003 | 242 | 0.050 |
Why?
|
| Colombia | 1 | 2020 | 11 | 0.050 |
Why?
|
| Weights and Measures | 1 | 2020 | 7 | 0.050 |
Why?
|
| Contraindications | 1 | 2020 | 73 | 0.050 |
Why?
|
| Perception | 1 | 2021 | 153 | 0.050 |
Why?
|
| Myocardium | 1 | 2022 | 521 | 0.050 |
Why?
|
| Consensus | 1 | 2021 | 302 | 0.050 |
Why?
|
| Electrodes, Implanted | 1 | 2019 | 163 | 0.040 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2017 | 7 | 0.040 |
Why?
|
| Prosthesis Fitting | 1 | 2017 | 15 | 0.040 |
Why?
|
| Curriculum | 1 | 2021 | 491 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1809 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 1025 | 0.040 |
Why?
|
| Heart Injuries | 1 | 2016 | 15 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 1 | 2017 | 147 | 0.040 |
Why?
|
| Patient Selection | 1 | 2020 | 667 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 1 | 1996 | 141 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 1996 | 126 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 556 | 0.040 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 178 | 0.040 |
Why?
|
| Thromboxane B2 | 1 | 1995 | 11 | 0.040 |
Why?
|
| Raffinose | 1 | 1995 | 23 | 0.040 |
Why?
|
| Partial Pressure | 1 | 1995 | 49 | 0.040 |
Why?
|
| Indomethacin | 1 | 1995 | 60 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 620 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2019 | 944 | 0.040 |
Why?
|
| Reperfusion | 1 | 1995 | 26 | 0.040 |
Why?
|
| Vascular Resistance | 1 | 1995 | 99 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1625 | 0.030 |
Why?
|
| Glutathione | 1 | 1995 | 102 | 0.030 |
Why?
|
| Allopurinol | 1 | 1995 | 80 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2015 | 103 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 276 | 0.030 |
Why?
|
| Stomach | 1 | 2015 | 110 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 426 | 0.030 |
Why?
|
| Rabbits | 1 | 1995 | 657 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 590 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 826 | 0.030 |
Why?
|
| Adenosine | 1 | 1995 | 218 | 0.030 |
Why?
|
| Oxygen | 1 | 1995 | 708 | 0.020 |
Why?
|
| Insulin | 1 | 1995 | 1131 | 0.020 |
Why?
|
| Blood Pressure | 1 | 1995 | 1163 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 1996 | 69 | 0.010 |
Why?
|
| Carotid Stenosis | 1 | 1996 | 103 | 0.010 |
Why?
|
| Animals | 1 | 1995 | 25878 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1996 | 968 | 0.010 |
Why?
|